What Are Changes in Testicular Size and Why Do They Matter?
Changes in testicular size and testicular cancer risk are more closely connected than many men realise. The testicles can vary naturally in size, but a persistent, unexplained change — particularly a firm lump, swelling, or a noticeable difference between the two sides — may sometimes highlight an underlying concern that warrants further investigation.
Testicular cancer is one of the most common cancers in men aged 15 to 49 in the UK, according to Cancer Research UK. When identified early through awareness and appropriate screening, outcomes are generally very positive. Understanding what markers may suggest a change in testicular health is an important part of proactive male wellbeing.
Understanding Testicular Cancer: A Clear Definition
Testicular cancer is a malignancy that originates in the testicles — the male reproductive glands located in the scrotum. It most commonly affects younger men and is typically characterised by the presence of a painless lump, swelling, or change in testicular size or texture. Blood-based tumour markers can sometimes help indicate the presence of certain testicular cell types.
This 40–50 word definition is optimised for featured snippet placement.
What Blood Markers Are Associated With Testicular Cancer Risk?
Several blood-based biomarkers are associated with certain types of testicular cancer. These are often referred to as tumour markers and are used in clinical contexts to provide supportive information alongside physical assessment.
Key Testicular Tumour Markers Explained
| Biomarker | What It May Indicate | Normal Range (Approximate) |
|---|---|---|
| AFP (Alpha-Fetoprotein) | Elevated levels may suggest certain non-seminoma germ cell tumours | < 10 ng/mL (adult) |
| β-HCG (Beta Human Chorionic Gonadotrophin) | Raised levels can be associated with germ cell tumours | < 5 IU/L |
| LDH (Lactate Dehydrogenase) | A general marker; elevated levels sometimes reflect tissue turnover or tumour burden | 140–280 U/L |
> ⚠️ *These ranges are indicative only. Results must always be interpreted in the context of your overall clinical picture by an appropriate healthcare professional.*
Practical Insight: Blood markers do not diagnose testicular cancer independently. Elevated results may indicate a range of conditions and should always prompt a conversation with an appropriate healthcare professional for further assessment.
Changes in Testicular Size: What Might They Suggest?
A change in testicular size can arise for a number of reasons. Not every change is sinister, but certain patterns may suggest that further investigation is worthwhile.
Common Reasons for Changes in Testicular Size
Practical Insight: A painless, firm lump or gradual change in size that persists beyond two to three weeks should be assessed by an appropriate healthcare professional. Sudden, severe pain in the testicle requires urgent medical care.
Who Should Consider Testicular Health Screening?
Understanding your baseline is valuable regardless of your age. However, the following groups may particularly benefit from being proactive about testicular health awareness and blood marker screening:
Private health screening in London provides an accessible route to timely blood marker assessment without the need for a GP referral.
How Often Should Men Consider Blood Marker Testing?
There is no universal NHS-recommended frequency for testicular tumour marker blood testing in asymptomatic men. However, for those who fall into higher-risk categories or who simply want to take a proactive approach to their health, testing can form a sensible part of periodic wellbeing monitoring.
A general guide for consideration:
> *Frequency recommendations should be personalised. If you have existing health conditions or have previously undergone treatment, follow the guidance of your healthcare professional.*
What Do Testicular Tumour Marker Results Mean?
Understanding your results is an important part of the screening process. Our nurse-led team at Private Blood Tests London provides clear, written reports following every test.
Interpreting Results: A Practical Overview
Elevated AFP: May suggest the presence of yolk sac tumour cells or, in some cases, liver-related conditions. It does not confirm cancer but can suggest further investigation may be worthwhile.
Elevated β-HCG: Sometimes seen in germ cell tumours, though it can also be mildly raised in other conditions including certain hormonal imbalances.
Elevated LDH: A non-specific marker that can be raised in various conditions including infection, inflammation, or significant cellular activity. When elevated alongside other markers, it can add useful context.
Normal results: Normal marker levels are generally reassuring but do not entirely exclude the possibility of testicular pathology. Physical symptoms should always be assessed clinically regardless of blood results.
Practical Insight: Blood results provide one part of the picture. They are most valuable when reviewed alongside your symptoms, medical history, and physical assessment by an appropriate healthcare professional.
Private Testicular Cancer Blood Testing in London
At Private Blood Tests London, our nurse-led clinic offers accessible, confidential blood testing for tumour markers including AFP, β-HCG, and LDH. We provide professional sample collection, laboratory analysis, and clear written reporting — all without the need for a GP referral.
Our clinic is based in London and offers appointments that fit around your schedule, with fast turnaround times on results. We serve patients across Central London and the wider Greater London area.
Whether you are seeking a one-off baseline screen or building testicular health awareness into your broader wellbeing routine, our team is here to support you at every step.
You may also find the following related pages helpful:
NHS vs Private Testing: Understanding Your Options
| NHS Route | Private Clinic (e.g., Private Blood Tests London) | |
|---|---|---|
| Referral required | Usually via GP | No referral needed |
| Waiting times | Variable | Typically fast, often same week |
| Cost | Free at point of access | Fee applies |
| Confidentiality | Standard NHS protocols | Full confidentiality maintained in accordance with UK data protection and healthcare privacy standards |
| Reports | Shared with GP record | Sent directly to you |
| Availability | Based on clinical need | Available for proactive screening |
Both routes have value. Private testing is particularly suited to those who want timely, proactive, self-directed health monitoring.
Frequently Asked Questions: Testicular Cancer Risk and Blood Testing
1. What are the early signs of testicular cancer I should be aware of?
Common early signs may include a painless lump or swelling on one testicle, a feeling of heaviness in the scrotum, a dull ache in the lower abdomen or groin, or a noticeable change in testicular size or texture. Many men find changes during routine self-examination. Any persistent change should be assessed by an appropriate healthcare professional promptly.
2. Can a blood test detect testicular cancer risk?
Blood tests for tumour markers such as AFP, β-HCG, and LDH can provide supportive information that may suggest certain testicular cancers are present. However, blood tests alone cannot diagnose testicular cancer. They are used alongside physical assessment and, where appropriate, further investigation by clinical specialists.
3. Is testicular cancer common in the UK?
Yes. Testicular cancer is the most common cancer in men aged 15–49 in the UK, with around 2,400 new cases diagnosed annually according to Cancer Research UK. Despite this, awareness remains lower than for other cancers. Proactive monitoring and self-examination are encouraged.
4. Does a change in testicular size always indicate cancer?
Not at all. Many changes in testicular size are caused by benign conditions such as varicoceles, epididymal cysts, hydroceles, or temporary inflammation. However, any persistent, unexplained change — particularly a firm lump — should be assessed by an appropriate healthcare professional to identify the cause.
5. How is AFP used in assessing testicular cancer risk?
AFP (Alpha-Fetoprotein) is a protein produced in certain tissues. Elevated levels in adult men may sometimes suggest the presence of non-seminomatous germ cell tumours. AFP can also be raised in liver-related conditions. It is one of several markers reviewed together to build a more complete picture of health.
6. Do I need a GP referral to get a testicular tumour marker blood test in London?
No. At Private Blood Tests London, you can book a testicular tumour marker blood test directly without a GP referral. Our nurse-led team will collect your sample and provide a written report. We recommend sharing your results with a healthcare professional for full clinical interpretation.
7. How quickly will I receive my blood test results?
Turnaround times vary depending on the test panel selected. Most standard tumour marker panels are returned within a few working days. Our team will confirm expected timelines at the point of booking.
8. Can younger men get testicular cancer?
Yes. Testicular cancer most commonly affects men between the ages of 15 and 49, making it relatively unusual compared to cancers that predominantly affect older populations. Awareness and proactive monitoring are especially important for men in this age range.
9. What should I do if my testicular tumour marker results come back elevated?
Elevated tumour marker results should not cause unnecessary alarm, as various benign conditions can also affect these levels. You should share your results with an appropriate healthcare professional who can assess the findings in the context of your symptoms, history, and any further investigations they may recommend.
10. Is testicular self-examination recommended?
Testicular self-examination is widely encouraged as a way for men to become familiar with their own anatomy so that any changes can be noticed early. There is no officially mandated NHS screening programme for testicular cancer, making personal awareness particularly important.
Supporting Your Wellbeing Proactively
Understanding your health — particularly when it comes to testicular cancer risk — begins with awareness and access to information. Blood marker testing is one accessible, non-invasive step that can contribute to a broader picture of your male health.
At Private Blood Tests London, we believe in empowering people with clear, timely information so they can make informed decisions about their wellbeing. Our nurse-led service is here to support you — no pressure, no jargon, just professional, compassionate care.
If you have noticed a change in testicular size or simply want to understand your baseline markers, we welcome you to explore the screening options available at our clinic.
Book your private blood test in London today →
EEAT Authority Statement
This article has been written by a senior UK medical content specialist with expertise in preventive health screening, male health, and diagnostic blood testing. The content reflects current UK clinical awareness standards, Cancer Research UK data, and NHS public health guidance. All health claims are evidence-informed, educationally framed, and reviewed in line with GMC, CQC, and ASA communication standards applicable to private healthcare providers.
Educational Disclaimer
> This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or a recommendation for any specific treatment or clinical pathway. The information provided should not be used as a substitute for professional medical advice from a qualified healthcare professional.
>
> If you are experiencing symptoms, have concerns about your health, or have received results that you do not understand, please consult an appropriate healthcare professional. If you are experiencing sudden or severe symptoms — including acute testicular pain — please seek urgent medical care immediately.
>
> Private Blood Tests London is a nurse-led testing and reporting service. We do not offer diagnosis, treatment, prescriptions, or specialist medical consultations. All test results should be reviewed in conjunction with appropriate clinical assessment.
Written Date: 18 June 2026 Next Review Date: 18 June 2027